Overview

Guillaume Blivet is an entrepreneur and innovator with over 15 years of global experience across multiple fields of healthcare, medical technologies, and disease management (national health institutions, Medco, which became Express Scripts, MedTechs). He specializes in public health (MPH) and also holds an Executive MBA.

A specialist in the healthcare sector and medical technologies, he is the Innovation Director of REGEnLIFE, a NeuroTech company he founded in 2016. This company develops a new medical device dedicated to people living with neurodegenerative diseases, including Alzheimer’s disease. This patented therapeutic solution is a non-invasive and painless application that comes in the form of a headset and an abdominal belt that together target both the brain and the gut.

He is also part of the editorial board of the Journal on Alzheimer’s Disease and co-chair of the International Symposium on Concussion in Sport.